Cargando…
Emerging strategies on in silico drug development against COVID-19: challenges and opportunities
The importance of coronaviruses as human pathogen has been highlighted by the recent outbreak of SARS-CoV-2 leading to the search of suitable drugs to overcome respiratory infections caused by the virus. Due to the lack of specific drugs against coronavirus, the existing antiviral and antimalarial d...
Autores principales: | Yadav, Manisha, Dhagat, Swasti, Eswari, J. Satya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438372/ https://www.ncbi.nlm.nih.gov/pubmed/32827661 http://dx.doi.org/10.1016/j.ejps.2020.105522 |
Ejemplares similares
-
Opportunistic Challenges of Computer-aided Drug Discovery of Lipopeptides: New Insights for Large Molecule Therapeutics
por: Yadav, Manisha, et al.
Publicado: (2023) -
Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach
por: Yadav, Manisha, et al.
Publicado: (2022) -
Vaccines against candidiasis: Status, challenges and emerging opportunity
por: Sahu, Satya Ranjan, et al.
Publicado: (2022) -
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
por: Meqbil, Yazan J., et al.
Publicado: (2022) -
Molecules against Covid-19: An in silico approach for drug development
por: Bharti, Rhythm, et al.
Publicado: (2021)